Abnormalities in the regulators of angiogenesis in patients with scleroderma
about
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populationsCorrelations between angiogenic factors and capillaroscopic patterns in systemic sclerosis.Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosisA tandem repeat of a fragment of Listeria monocytogenes internalin B protein induces cell survival and proliferationPulmonary arterial hypertension associated with systemic sclerosis.The right ventricle in scleroderma (2013 Grover Conference Series).Vascular involvement in systemic sclerosis (scleroderma).Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.The current state of biomarkers in systemic sclerosisBiomarkers of pulmonary hypertension in patients with scleroderma: a case-control study.Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.Activation of the Thromboxane A2 Receptor by 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in SclerodermaMechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis.Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.The contribution of platelets to the pathogenesis of Raynaud's phenomenon and systemic sclerosis.Platelets in pulmonary hypertension: a causative role or a simple association?Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.Transforming growth factor β--at the centre of systemic sclerosis.Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.Biomarkers in systemic sclerosis: Their potential to predict clinical courses.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.The Circulating Levels of Selenium, Zinc, Midkine, Some Inflammatory Cytokines, and Angiogenic Factors in Mitral Chordae Tendineae Rupture.Measurement of Serum Klotho in Systemic Sclerosis.Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissuesEndostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria.Circulating angiopoietin and Tie-2 levels in systemic sclerosis.Gingival crevicular fluid and its immune mediators in the proteomic era.Microvascular involvement in Systemic Sclerosis and Systemic Lupus Erythematosus.Potential biomarkers in patients with systemic sclerosis.Skin sclerosis as a manifestation of POEMS syndrome.Semaphorin 3A: an immunoregulator in systemic sclerosis
P2860
Q33653276-7229D699-1777-4965-AB1D-7FC5240CAB87Q33765564-75EED761-F9FD-4E88-A4C8-6F62B2D5585DQ33955502-E45DBE24-4459-4E6F-A670-A170A16381F8Q34081935-406A7BA8-540E-4147-AFE8-09B3BB58E60EQ34182447-EC6B1DBA-F186-4CDB-9735-3DB0237A067AQ34426051-D91B6520-BCCC-4C67-846D-BE2DFD50165BQ35002423-46A39B12-33BB-4B01-BAAD-AC5BC8978A6AQ35517421-F54DF1DC-7CD3-45F0-B9C7-FB9F29A95A7FQ35557424-B8DFFEA3-B1A3-42DE-8F8F-0DA808D084B8Q35663931-0D45A4CE-9723-4EE1-B63F-C9FDFB8CB9DBQ35896754-F33418E2-DDED-4284-8405-EA493F013160Q35923222-D5AE3220-25D6-46C5-A8D1-B6413CE690F5Q36001528-1240CF33-7630-4436-98CD-E65CB04162E9Q36129874-F91135AE-B3FE-4EEE-A62B-FB184F50EEC4Q36289139-603A4132-9C30-4D16-B3CA-8E29DDA9CF7DQ37310583-17482087-8C5D-4E90-AC13-4A05133EEC7BQ37768336-7DBD7777-A757-4DDB-BD70-151F9135C379Q38042445-D173BD91-F61D-442E-A491-F785D1F8DDECQ38051350-7957FCFF-C46C-4E5F-850C-7714288FF18CQ38071978-D4673575-139B-4C07-8C3C-A7F3FEF4421AQ38241227-982B6D29-4F8A-4120-84F1-1A457279E203Q38542662-51A2EC05-185C-4769-AF29-19F543FB1821Q38701985-DC8AD73A-F7E8-479D-9585-3CD8F87B6FFCQ38771824-779C5E0D-1021-4567-A0DE-027E0C99E1D0Q39100245-41BD5413-E7A5-46FD-B308-3EC70B755165Q40494777-03E21587-61BE-41AE-A37B-316F3DE131FBQ41196336-9A467A33-A788-4BAF-B3CE-D30353A46764Q41622879-13DAD48F-5068-4B21-9E39-0A2656F9A324Q42033229-5B017917-55A8-430E-B040-FC453F898CBAQ43865583-5E9D47B1-5CE4-4F02-8917-0A11461661CAQ44016255-6CDF04D3-5BB2-4CB5-ADD1-5A6429DE98CFQ47343603-2C092280-89CF-48DC-B3E8-2FC8D6A00ED3Q47660081-ADE45796-F386-45E0-B8C7-686E6455A43FQ47662284-74F8EFDE-98A6-4358-A829-0D1904260E7FQ48566990-57C80180-2B32-4EC4-B500-2382B5DB2ADAQ58040981-F27C7CB8-AB1E-41AE-BBFA-B4CE9F734F1C
P2860
Abnormalities in the regulators of angiogenesis in patients with scleroderma
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@ast
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@en
type
label
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@ast
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@en
prefLabel
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@ast
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@en
P2860
P356
P1476
Abnormalities in the regulators of angiogenesis in patients with scleroderma
@en
P2093
Fredrick M Wigley
P2860
P304
P356
10.3899/JRHEUM.080516
P407
P577
2009-02-17T00:00:00Z